Rosetta Genomics (Israel)
Rosetta Genomics Ltd. was a molecular diagnostics company with offices in Israel and the United States that uses micro-ribonucleic acid biomarkers to develop diagnostic tests designed to differentiate between various types of cancer. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Rosetta Genomics (Israel), Israel, covering academic research published from 2002 to 2024. Read More.
Open Access Percentage
46%
Total
Publications
101
Total Open
Publications
46
Total
Citations
13K
Open Access
Percentage
46%
Total
Publications
101
Total Open
Publications
46
Total
Citations
13K
Breakdown
Publisher Open
21%
Both
22%
Other Platform Open
3%
Closed
54%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 47%
20
Hybrid 9%
4
No Guarantees 44%
19
Other Platform Open
Domain 88%
22
Institution 32%
8
Public 8%
2
Other Internet 4%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 22 |
doaj.org OAI-PMH Repository | Institution | 7 |
Figshare | Public | 2 |
Politecnico di Torino | Institution | 1 |
National Institutes of Health | Institution | 1 |
Europe PMC | Domain | 1 |
DOI | Other Internet | 1 |